Annual EBITDA
-$233.50 M
-$55.97 M-31.53%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual EBITDA is -$233.50 million, with the most recent change of -$55.97 million (-31.53%) on December 31, 2023.
- During the last 3 years, RNA annual EBITDA has fallen by -$189.72 million (-433.43%).
- RNA annual EBITDA is now -2208.42% below its all-time high of -$10.12 million, reached on December 31, 2018.
Performance
RNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$97.42 M
-$15.48 M-18.90%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly EBITDA is -$97.42 million, with the most recent change of -$15.48 million (-18.90%) on September 1, 2024.
- Over the past year, RNA quarterly EBITDA has dropped by -$39.37 million (-67.80%).
- RNA quarterly EBITDA is now -4574.86% below its all-time high of -$2.08 million, reached on March 31, 2019.
Performance
RNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$322.04 M
-$39.37 M-13.93%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM EBITDA is -$322.04 million, with the most recent change of -$39.37 million (-13.93%) on September 1, 2024.
- Over the past year, RNA TTM EBITDA has dropped by -$101.82 million (-46.24%).
- RNA TTM EBITDA is now -15352.83% below its all-time high of -$2.08 million, reached on March 31, 2019.
Performance
RNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.5% | -67.8% | -46.2% |
| 3 y3 years | -433.4% | -234.7% | -238.2% |
| 5 y5 years | -2208.4% | -1802.1% | -1794.5% |
RNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.9% | at low | -185.3% | at low | -174.3% | at low |
| 5 y | 5-year | -1273.6% | at low | -1544.6% | at low | -1794.5% | at low |
| alltime | all time | -2208.4% | at low | -4574.9% | at low | <-9999.0% | at low |
Avidity Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$97.42 M(+18.9%) | -$322.04 M(+13.9%) |
| Jun 2024 | - | -$81.94 M(+7.0%) | -$282.67 M(+11.8%) |
| Mar 2024 | - | -$76.55 M(+15.8%) | -$252.84 M(+8.3%) |
| Dec 2023 | -$233.50 M(+31.5%) | -$66.13 M(+13.9%) | -$233.50 M(+6.0%) |
| Sep 2023 | - | -$58.06 M(+11.4%) | -$220.21 M(+6.5%) |
| Jun 2023 | - | -$52.10 M(-8.9%) | -$206.71 M(+3.1%) |
| Mar 2023 | - | -$57.20 M(+8.3%) | -$200.59 M(+13.0%) |
| Dec 2022 | -$177.53 M(+51.2%) | -$52.84 M(+18.6%) | -$177.53 M(+8.9%) |
| Sep 2022 | - | -$44.56 M(-3.1%) | -$163.02 M(+10.5%) |
| Jun 2022 | - | -$45.98 M(+34.6%) | -$147.57 M(+15.5%) |
| Mar 2022 | - | -$34.15 M(-10.9%) | -$127.81 M(+8.9%) |
| Dec 2021 | -$117.41 M | -$38.34 M(+31.7%) | -$117.41 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$29.10 M(+11.0%) | -$95.23 M(+22.9%) |
| Jun 2021 | - | -$26.22 M(+10.4%) | -$77.47 M(+25.8%) |
| Mar 2021 | - | -$23.75 M(+47.0%) | -$61.60 M(+40.7%) |
| Dec 2020 | -$43.77 M(+157.5%) | -$16.16 M(+42.5%) | -$43.77 M(+30.3%) |
| Sep 2020 | - | -$11.34 M(+9.5%) | -$33.59 M(+22.7%) |
| Jun 2020 | - | -$10.35 M(+74.7%) | -$27.38 M(+31.4%) |
| Mar 2020 | - | -$5.92 M(-0.9%) | -$20.84 M(+22.6%) |
| Dec 2019 | -$17.00 M(+68.1%) | -$5.98 M(+16.8%) | -$17.00 M(+54.3%) |
| Sep 2019 | - | -$5.12 M(+34.3%) | -$11.02 M(+86.9%) |
| Jun 2019 | - | -$3.81 M(+83.0%) | -$5.90 M(+183.0%) |
| Mar 2019 | - | -$2.08 M | -$2.08 M |
| Dec 2018 | -$10.12 M | - | - |
FAQ
- What is Avidity Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Avidity Biosciences?
- What is Avidity Biosciences annual EBITDA year-on-year change?
- What is Avidity Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Avidity Biosciences?
- What is Avidity Biosciences quarterly EBITDA year-on-year change?
- What is Avidity Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Avidity Biosciences?
- What is Avidity Biosciences TTM EBITDA year-on-year change?
What is Avidity Biosciences annual EBITDA?
The current annual EBITDA of RNA is -$233.50 M
What is the all time high annual EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high annual EBITDA is -$10.12 M
What is Avidity Biosciences annual EBITDA year-on-year change?
Over the past year, RNA annual EBITDA has changed by -$55.97 M (-31.53%)
What is Avidity Biosciences quarterly EBITDA?
The current quarterly EBITDA of RNA is -$97.42 M
What is the all time high quarterly EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high quarterly EBITDA is -$2.08 M
What is Avidity Biosciences quarterly EBITDA year-on-year change?
Over the past year, RNA quarterly EBITDA has changed by -$39.37 M (-67.80%)
What is Avidity Biosciences TTM EBITDA?
The current TTM EBITDA of RNA is -$322.04 M
What is the all time high TTM EBITDA for Avidity Biosciences?
Avidity Biosciences all-time high TTM EBITDA is -$2.08 M
What is Avidity Biosciences TTM EBITDA year-on-year change?
Over the past year, RNA TTM EBITDA has changed by -$101.82 M (-46.24%)